| Literature DB >> 24634197 |
Abstract
The redox-active transition metal copper is an essential trace element for growth and development and serves as a structural or catalytic cofactor for many enzymes in a range of physiological processes. Mammalian copper homeostasis is tightly regulated, and an imbalance in copper metabolism is implicated in various pathological disorders. Radioactive copper isotopes, in particular (64) Cu (t1/2 = 12.7 h) and (67) Cu (t1/2 = 62.01 h), have made important contributions to the understanding of copper metabolism in health and disease. This review gives a brief account of how radiolabelled copper(II) salts and bioreductive copper complexes have been used to trace copper uptake, transport and efflux in vitro and in vivo. Recently, positron emission tomography (PET) has emerged as a noninvasive tool to image copper metabolism in living subjects and (64) Cu-PET is investigated for the study of copper-related neurological disorders, genetic diseases and cancer.Entities:
Keywords: Alzheimer's disease; Wilson's disease; copper metabolism; radiocopper; tumour imaging
Mesh:
Substances:
Year: 2014 PMID: 24634197 DOI: 10.1002/jlcr.3155
Source DB: PubMed Journal: J Labelled Comp Radiopharm ISSN: 0362-4803 Impact factor: 1.921